Submitted by Anonymous (not verified) on 12 March 2026 - 8:00
Opinion/decision on a Paediatric investigation plan (PIP): Natpar, recombinant parathyroid hormone, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Endocrine disorders, PIP number: EMA/PE/0000225073
Source: